Israel treats bladder cancer using advanced surgical and oncological protocols tailored to tumor invasiveness. Primary methods include robotic-assisted cystectomy, transurethral resection (TURBT), and innovative therapies like hyperthermic intravesical chemotherapy and checkpoint inhibitors. Specialized centers like Sourasky Medical Center report a 90% average success rate for oncology treatments.
- Robotic surgery: Surgeons use the da Vinci system for precise bladder removals and reconstructions.
- Intravesical therapy: Doctors inject BCG or chemotherapy directly into the bladder to prevent recurrence.
- Advanced diagnostics: Clinics utilize blue light cystoscopy (PDD) to identify small, non-visible tumors.
- Precision oncology: Targeted FGFR inhibitors and immunotherapy drugs like Keytruda treat advanced cases.
Bookimed Expert Insight: Israeli oncology centers often provide specialized access to combined protocols not widely available elsewhere. For example, Sheba Medical Center is a global leader in CAR-T and TIL immunotherapies. Patients requesting complex care can find comprehensive packages, such as those at Sourasky Medical Center for $52,300, which include preoperative tests, anesthesia, and internal transfers.
Patient Consensus: Patients note that using blue light cystoscopy during surgery helps catch more tumors than standard procedures. Many emphasize the importance of getting a remote second opinion from Israeli specialists to refine treatment plans for invasive cancer.
